SCHEMBL28103103

SCHEMBL28103103

CCCC1COOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL486549 0.82
SCHEMBL13963187 0.82
SCHEMBL5553290 0.81
SCHEMBL8461435 0.77
SCHEMBL13381323 0.75 ALDH1A1 (0.36)
SCHEMBL6505290 0.75
SCHEMBL12889540 0.75 ALDH1A1 (0.36)
SCHEMBL25368925 0.73
Propanol SCHEMBL1011878 0.73 FYN (0.39)
SCHEMBL13381321 0.73 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106008322-A BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2016-10-12 CN disclosed